As of 4:00pm ET
| -0.10 / -2.13%|
The 6 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 5.50, with a high estimate of 21.00 and a low estimate of 4.00. The median estimate represents a +19.83% increase from the last price of 4.59.
The current consensus among 6 polled investment analysts is to Hold stock in NewLink Genetics Corp. This rating has held steady since April, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.